Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
暂无分享,去创建一个
Andrea Bild | Mike West | Zeljko Vujaskovic | P Kelly Marcom | Mark W Dewhirst | M. West | H. Dressman | J. Olson | J. Nevins | Chris Hans | M. Dewhirst | A. Bild | E. Rosen | K. Blackwell | P. Marcom | Ž. Vujašković | E. Jones | Holly K Dressman | Joseph R Nevins | Jeffrey Marks | V. Liotcheva | Kimberly Blackwell | Ellen L Jones | Christopher Hans | John A Olson | Eric Rosen | Vlayka B Liotcheva | J. Marks
[1] M. Dewhirst,et al. Thermochemoradiotherapy Improves Oxygenation in Locally Advanced Breast Cancer , 2004, Clinical Cancer Research.
[2] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[3] A. Harris,et al. Hypoxia‐induced pathways in breast cancer , 2002, Microscopy research and technique.
[4] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[5] G L Rosner,et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. , 1994, International journal of radiation oncology, biology, physics.
[6] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[7] J. Stec,et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Steinberg,et al. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Bryant,et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.
[10] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[11] R. Bicknell,et al. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. , 1998, The Biochemical journal.
[12] F. Penault-Llorca,et al. Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy , 2002, Breast Cancer Research and Treatment.
[13] D. Hedley,et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[15] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[16] M. West,et al. Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.
[17] F. Penault-Llorca,et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer , 2002, British Journal of Cancer.
[18] E. Rosen,et al. Ultrasound guided pO 2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[19] Syed Mohsin,et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.